Literature DB >> 28894498

Guidelines for the management of atopic dermatitis (eczema) for pharmacists.

Ian T Y Wong1, Ross T Tsuyuki1, Amanda Cresswell-Melville1, Philip Doiron1, Aaron M Drucker1.   

Abstract

Entities:  

Year:  2017        PMID： 28894498      PMCID： PMC5582672          DOI： 10.1177/1715163517710958

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  66 in total

1.  Safety and tolerability of a body wash and moisturizer when applied to infants and toddlers with a history of atopic dermatitis: results from an open-label study.

Authors:  Eric Simpson; Nathan S Trookman; Ronald L Rizer; Norman Preston; Luz E Colón; Lori A Johnson; Ronald W Gottschalk
Journal:  Pediatr Dermatol       Date:  2012-07-08       Impact factor: 1.588

2.  Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.

Authors:  Amy S Paller; Wynnis L Tom; Mark G Lebwohl; Robin L Blumenthal; Mark Boguniewicz; Robert S Call; Lawrence F Eichenfield; Douglass W Forsha; William C Rees; Eric L Simpson; Mary C Spellman; Linda F Stein Gold; Andrea L Zaenglein; Matilda H Hughes; Lee T Zane; Adelaide A Hebert
Journal:  J Am Acad Dermatol       Date:  2016-07-11       Impact factor: 11.527

3.  Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study.

Authors:  Kim A Papp; Thomas Werfel; Regina Fölster-Holst; Jean-Paul Ortonne; Paul C Potter; Yves de Prost; Miles J Davidson; Nathalie Barbier; Hans-Peter Goertz; Carle Paul
Journal:  J Am Acad Dermatol       Date:  2005-02       Impact factor: 11.527

4.  Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.

Authors:  Lawrence F Eichenfield; Wynnis L Tom; Timothy G Berger; Alfons Krol; Amy S Paller; Kathryn Schwarzenberger; James N Bergman; Sarah L Chamlin; David E Cohen; Kevin D Cooper; Kelly M Cordoro; Dawn M Davis; Steven R Feldman; Jon M Hanifin; David J Margolis; Robert A Silverman; Eric L Simpson; Hywel C Williams; Craig A Elmets; Julie Block; Christopher G Harrod; Wendy Smith Begolka; Robert Sidbury
Journal:  J Am Acad Dermatol       Date:  2014-05-09       Impact factor: 11.527

5.  The Financial and Emotional Impact of Atopic Dermatitis on Children and Their Families.

Authors:  Michelle G Filanovsky; Suwimon Pootongkam; Joan E Tamburro; Mary C Smith; Stephen J Ganocy; Susan T Nedorost
Journal:  J Pediatr       Date:  2015-11-23       Impact factor: 4.406

6.  Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study.

Authors:  A Peserico; G Städtler; M Sebastian; R Suarez Fernandez; K Vick; T Bieber
Journal:  Br J Dermatol       Date:  2008-02-16       Impact factor: 9.302

7.  Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial.

Authors:  J Schmitt; K Schäkel; R Fölster-Holst; A Bauer; R Oertel; M Augustin; W Aberer; T Luger; M Meurer
Journal:  Br J Dermatol       Date:  2009-10-26       Impact factor: 9.302

8.  Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.

Authors:  A Wollenberg; S Reitamo; G Girolomoni; M Lahfa; T Ruzicka; E Healy; A Giannetti; T Bieber; J Vyas; M Deleuran
Journal:  Allergy       Date:  2008-07       Impact factor: 13.146

9.  Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.

Authors:  R M R Hearn; A C Kerr; K F Rahim; J Ferguson; R S Dawe
Journal:  Br J Dermatol       Date:  2008-09       Impact factor: 9.302

10.  Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016.

Authors:  Hidehisa Saeki; Takeshi Nakahara; Akio Tanaka; Kenji Kabashima; Makoto Sugaya; Hiroyuki Murota; Tamotsu Ebihara; Yoko Kataoka; Michiko Aihara; Takafumi Etoh; Norito Katoh
Journal:  J Dermatol       Date:  2016-10       Impact factor: 4.005
View more
  6 in total

1.  Igalan from Inula helenium (L.) suppresses the atopic dermatitis-like response in stimulated HaCaT keratinocytes via JAK/STAT3 signaling.

Authors:  Thien T P Dao; Kwangho Song; Jee Young Kim; Yeong Shik Kim
Journal:  Inflamm Res       Date:  2020-01-30       Impact factor: 4.575

Review 2.  Molecular and cellular mechanisms of itch and pain in atopic dermatitis and implications for novel therapeutics.

Authors:  Shawn G Kwatra; Laurent Misery; Claire Clibborn; Martin Steinhoff
Journal:  Clin Transl Immunology       Date:  2022-05-09

Review 3.  Mesenchymal Stem Cells and Atopic Dermatitis: A Review.

Authors:  Sérgio Ricardo Teixeira Daltro; Cássio Santana Meira; Ivanilson Pimenta Santos; Ricardo Ribeiro Dos Santos; Milena Botelho Pereira Soares
Journal:  Front Cell Dev Biol       Date:  2020-05-14

4.  Addressing topical corticosteroid phobia in atopic dermatitis: The role of the pharmacist.

Authors:  Matthew Ladda; Philip Doiron
Journal:  Can Pharm J (Ott)       Date:  2021-02-20

Review 5.  Global Guidelines in Dermatology Mapping Project (GUIDEMAP), a systematic review of atopic dermatitis clinical practice guidelines: are they clear, unbiased, trustworthy and evidence based (CUTE)?

Authors:  Bernd W M Arents; Esther J van Zuuren; Sofieke Vermeulen; Jan W Schoones; Zbys Fedorowicz
Journal:  Br J Dermatol       Date:  2022-05       Impact factor: 11.113

6.  The effectiveness and safety of acupuncture for patients with atopic eczema: a systematic review and meta-analysis.

Authors:  Ruimin Jiao; Zhongyang Yang; Yang Wang; Jing Zhou; Yuxiao Zeng; Zhishun Liu
Journal:  Acupunct Med       Date:  2019-09-09       Impact factor: 2.267
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.